Amrubicin and carboplatin

2 trials

Sponsors

Tohoku University Hospital

Conditions

Small-cell lung cancerThymoma/Thymic carcinoma

Unknown Phase

Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma

Active, not recruitingJPRN-UMIN000002619

Tohoku University HospitalThymoma/Thymic carcinoma

Start: 2008-09-01Target: 40Updated: 2026-06-29

Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer

Active, not recruitingJPRN-UMIN000002618

Tohoku University HospitalSmall-cell lung cancer

Start: 2008-09-01Target: 30Updated: 2026-06-29